Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

Quality of life profile of general Vietnamese population using EQ-5D-5L

Authors: Long Hoang Nguyen, Bach Xuan Tran, Quynh Ngoc Hoang Le, Tung Thanh Tran, Carl A. Latkin

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Health-related quality of life (HRQOL) is a vital benchmark to assess the effects of health interventions and policies. Measuring HRQOL of the general population is essential to establish a reference for health outcomes evaluations. However, evidence on HRQOL of general populations in low and middle income countries is very limited. This study aimed to measure HRQOL of the Vietnamese population by using the EuroQol-5 dimensions-5 levels (EQ-5D-5L) instrument and determine its associated factors.

Methods

A cross-sectional study was performed in Hanoi with 1571 residences in Hanoi, the capital city of Vietnam. EQ-5D-5L and EQ- visual analogue scale (EQ-VAS) were used to assess HRQOL. Potential covariates included socio-demographic characteristics, having acute symptoms in the last four weeks, chronic diseases in the last three months, having multiple health issues, and health service utilisation in the last twelve months. A generalized linear model was employed to identify the association between HRQOL and covariates.

Results

Overall, the mean EQ-5D utility index was 0.91 (SD = 0.15), and the mean EQ-VAS score was 87.4 (SD = 14.3). The highest proportion of respondents reporting any problems was in Usual activities (24.3%), followed by Anxiety/Depression (15.2%) and Pain/Discomfort (10.0%), while the lowest percentage was in Self-care (2.5%). Lower HRQOL composite scores were related to unemployment, lower income, higher education, living in urban areas, having chronic diseases, having multiple health issues and using health service. For any health problem self-reported by respondents, the health utility reduced by 0.02 (respiratory diseases) to 0.15 (musculoskeletal diseases).

Conclusions

Health utility of the general population and reductions for self-reported health problems in this study are useful for future population health evaluations and comparisons. It also informs the development of interventions to reduce health problems of the general population.
Literature
1.
Ravens-Sieberer U. Measuring and monitoring quality-of-life in population surveys: still a challenge for public health research. Soz Praventivmed. 2002;47:203–4.PubMed
2.
Kruk ME, Freedman LP. Assessing health system performance in developing countries: a review of the literature. Health Policy. 2008;85:263–76.CrossRefPubMed
3.
Tran BX, Ohinmaa A, Nguyen LT, Nguyen TA, Nguyen TH. Determinants of health-related quality of life in adults living with HIV in Vietnam. AIDS Care. 2011;23:1236–45.CrossRefPubMed
4.
Brazier J, Ratcliffe J, Tsuchiya A, Salomon JA. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford, UK: Oxford University Press; 2016.CrossRef
5.
Kularatna S, Whitty JA, Johnson NW, Jayasinghe R, Scuffham PA. EQ-5D-3L Derived Population Norms for Health Related Quality of Life in Sri Lanka. PLoS One. 2014;9:e108434.CrossRefPubMedPubMedCentral
6.
Tran BX, Hwang J, Nguyen LH, Nguyen AT, Latkin NRK, Tran NK, Minh Thuc VT, Nguyen HLT, Phan HTT, Le HT, et al. Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam. PLoS One. 2016;11:e0168687.CrossRefPubMedPubMedCentral
7.
8.
Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Res Ther. 2015;17(1):143.
9.
Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7:541–6.CrossRefPubMed
10.
Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61:102–9.CrossRefPubMed
11.
Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006;4:70.CrossRefPubMedPubMedCentral
12.
13.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRefPubMedPubMedCentral
14.
Augustovski F, Rey-Ares L, Irazola V, Garay OU, Gianneo O, Fernandez G, Morales M, Gibbons L, Ramos-Goni JM. An EQ-5D-5L value set based on Uruguayan population preferences. Qual Life Res. 2016;25:323–33.CrossRefPubMed
15.
Brennan DS, Teusner DN. Comparing UK, USA and Australian values for EQ-5D as a health utility measure of oral health. Community Dent Health. 2015;32:180–4.PubMed
16.
Feng Y, Devlin N, Herdman M. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes. 2015;13:171.CrossRefPubMedPubMedCentral
17.
Hinz A, Kohlmann T, Stobel-Richter Y, Zenger M, Brahler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23:443–7.CrossRefPubMed
18.
Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25:707–19.CrossRefPubMed
19.
Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes. 2012;10:132.CrossRefPubMedPubMedCentral
20.
Garcia-Gordillo MA, Adsuar JC, Olivares PR. Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011. Qual Life Res. 2016;25:1313–21.CrossRefPubMed
21.
McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual Life Outcomes. 2016;14:133.CrossRefPubMedPubMedCentral
22.
23.
Alberta HQCo: Alberta population norms for EQ-5D-5L. Alberta: Health Quality Council of Alberta; 2014.
24.
Perneger TV, Combescure C, Courvoisier DS. General population reference values for the French version of the EuroQol EQ-5D health utility instrument. Value Health. 2010;13:631–5.CrossRefPubMed
25.
Sorensen J, Davidsen M, Gudex C, Pedersen KM, Bronnum-Hansen H. Danish EQ-5D population norms. Scand J Public Health. 2009;37:467–74.CrossRefPubMed
26.
Nguyen LH, Nguyen LHT, Boggiano VL, Hoang CD, Van Nguyen H, Le HT, Le HQ, Tran TD, Tran BX, Latkin CA, et al. Quality of life and healthcare service utilization among methadone maintenance patients in a mountainous area of Northern Vietnam. Health Qual Life Outcomes. 2017;15:77.CrossRefPubMedPubMedCentral
27.
Nguyen LH, Tran BX, Nguyen HLT, Nguyen CT, Hoang CD, Le HQ, Van Nguyen H, Le HT, Tran TD, Latkin CA, TMT V. Psychological Distress Among Methadone Maintenance Patients in Vietnamese Mountainous Areas. AIDS Behav; 2017.
28.
Tran BX, Nguyen LH, Nong VM, Nguyen CT, Phan HT, Latkin CA. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduct J. 2016;13:4.CrossRefPubMedPubMedCentral
29.
Tran BXNL, Phan HT, Nguyen LK, Latkin CA. Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam. Harm Reduction J. 2015;12(1):29.CrossRef
30.
Nguyen LH, Nguyen HTT, Nguyen HLT, Tran BX, Latkin CA. Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas. Subst Abuse Treat Prev Policy. 2017;12:31.CrossRefPubMedPubMedCentral
31.
Tran BX, Huong LT, Hinh ND, Nguyen LH, Le BN, Nong VM, Thuc VT, Tho TD, Latkin C, Zhang MW, Ho RC. A study on the influence of internet addiction and online interpersonal influences on health-related quality of life in young Vietnamese. BMC Public Health. 2017;17:138.CrossRefPubMedPubMedCentral
32.
Zhang MWB, Tran BX, Huong LT, Hinh ND, Nguyen HLT, Tho TD, Latkin C, Ho RCM. Internet addiction and sleep quality among Vietnamese youths. Asian J Psychiatr. 2017;28:15–20.CrossRefPubMed
33.
Zhang MWB, Tran BX, Nguyen HLT, Le HT, Long NH, Le HT, Hinh ND, Tho TD, Le BN, Thuc VTM, et al. Using Online Respondent Driven Sampling for Vietnamese Youths’ Alcohol Use and Associated Risk Factors. Healthc Inform Res. 2017;23:109–18.CrossRefPubMedPubMedCentral
34.
Tran BX, Nguyen LH, Nong VM, Nguyen CT. Health status and health service utilization in remote and mountainous areas in Vietnam. Health Qual Life Outcomes. 2016;14:85.CrossRefPubMedPubMedCentral
35.
36.
37.
Cohen J. The Significance of a product moment rs. In: Hillsdale JC, editor. Statistical power analysis for the behavioural sciences. New Jersey: Lawrence Erlbaum Associates; 1988.
38.
Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, Sledge GW, Wood WC. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57:898–910.CrossRefPubMed
39.
Mihaylova B, Briggs A, O'Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897–916.CrossRefPubMed
40.
Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: Oxford University Press; 2015.
41.
Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–94.CrossRefPubMed
42.
Starkie HJ, Briggs AH, Chambers MG, Jones P. Predicting EQ-5D Values Using the SGRQ. Value Health. 2011;14:354–60.CrossRefPubMed
43.
David W. Hosmer, Lemeshow S: Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
44.
Scalone L, Cortesi PA, Ciampichini R, Cesana G, Mantovani LG. Health Related Quality of Life norm data of the Italian general population: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiol Biostatistics Public Health. 2015;12:11451–15.
45.
Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23:431–42.CrossRefPubMed
46.
Pullenayegum EM, Perampaladas K, Gaebel K, Doble B, Xie F. Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection? Eur J Health Econ. 2015;16:847–55.CrossRefPubMed
47.
Feng Y, Parkin D, Devlin NJ. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Qual Life Res. 2014;23:977–89.CrossRefPubMed
48.
Parkin D, Rice N, Devlin N. Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? Med Decis Mak. 2010;30:556–65.CrossRef
49.
Health CAfDaTi. Guidelines for the economic evaluation of health technologies. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006.
50.
Excellence NIfHaC. Guide to the methods of technology appraisal 2013. UK: NHS; 2013.
51.
Tran B, Nguyen L, Ohinmaa A, Maher R, Nong V, Latkin CA. Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis. BMC Health Serv Res. 2015;15:7.
52.
Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual Life Res. 2013;22:791–9.CrossRefPubMed
53.
Huber MB, Felix J, Vogelmann M, Leidl R. Health-Related Quality of Life of the General German Population in 2015: Results from the EQ-5D-5L. Int J Environ Res Public Health. 2017;14.
54.
Minister P. Decision 2351/QD-TTg, approving the National Strategy on Gender Equality for the 2011–2020 period. Hanoi: Vietnam Government; 2012.
55.
Patton GC, Coffey C, Sawyer SM, Viner RM, Haller DM, Bose K, Vos T, Ferguson J, Mathers CD. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet. 374:881–92.
56.
Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–323.CrossRefPubMed
57.
The Global Burden of Disease C, Adolescent Health C: Child and adolescent health from 1990 to 2015: Findings from the global burden of diseases, injuries, and risk factors 2015 study. JAMA Pediatr 2017, 171:573-592.
58.
Bowling A. Quality of life in older age: what older people say. Dordrecht: Springer; 2007.
59.
Van Nguyen T, Van Nguyen H, Duc Nguyen T, Van Nguyen T, The Nguyen T. Difference in quality of life and associated factors. J Prev Med Hyg. 2017;58:E63–71.PubMedPubMedCentral
60.
Huong NT, Ha LTH, Tien TQ. Determinants of Health-Related Quality of Life Among Elderly: Evidence From Chi Linh Town, Vietnam. Asia Pac J Public Health. 2017;29(5_suppl):84S–93S.
61.
Health Mo. Circular No. 02/2017/TT-BYT dated 15 th March 2017 of the Ministry of Health, stipulating the maximum levels in price list for medical examination and treatment services, which do not fall within the payment scope of Health Insurance Fund in the State-owned medical examination and treatment facilities and guidance on pricing and payment for medical examination and treatment in some cases. Hanoi: Ministry of Health; 2017.
62.
Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci. 1992;241:247–58.CrossRefPubMed
63.
Muntaner C, Eaton WW, Diala C, Kessler RC, Sorlie PD. Social class, assets, organizational control and the prevalence of common groups of psychiatric disorders. Soc Sci Med. 1998;47:2043–53.CrossRefPubMed
64.
Lin M, Chen Y, McDowell I. Increased risk of depression in COPD patients with higher education and income. Chron Respir Dis. 2005;2:13–9.CrossRefPubMed
65.
Goering P, Lin E, Campbell D, Boyle MH, Offord DR. Psychiatric disability in Ontario. Can J Psychiatr. 1996;41:564–71.CrossRef
Metadata
Title
Quality of life profile of general Vietnamese population using EQ-5D-5L
Authors
Long Hoang Nguyen
Bach Xuan Tran
Quynh Ngoc Hoang Le
Tung Thanh Tran
Carl A. Latkin
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0771-0

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue

Research

Patient-related outcome of unstable pelvic ring fractures stabilized with a minimal invasive screw-rod system

Research

Profile and predictors of health related quality of life among type II diabetes mellitus patients in Quetta city, Pakistan

Research

Predictors of physical and mental health in persons with morbid obesity attending a patient education course – a two-year follow-up study

Research

Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis

Research

Recent advances in analysis of differential item functioning in health research using the Rasch model

Research

Effect of chemotherapy counseling by pharmacists on quality of life and psychological outcomes of oncology patients in Malaysia: a randomized control trial